FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2987306747> ?p ?o ?g. }

• W2987306747 endingPage "3528" @default.
• W2987306747 startingPage "3528" @default.
• W2987306747 abstract "Red blood cell (RBC) homeostasis tightly balances production of new erythroid cells and clearance of damaged or senescent RBCs. Macrophages play a central role in this process in the specialized niches termed erythroblastic island. Macrophages expressing CD169 (Sialoadhesin or Siglec-1), F4/80, CD11b, VCAM-1, ER-HR3 and Ly-6G play important roles in physiological and pathological erythropoiesis. Sickle cell disease (SCD) is characterized by chronic stress erythropoiesis as a compensatory mechanism for anemia. Recent publications have detected macrophage hypercellularity correlated with erythroid hyperplasia in genetic models of erythrocytosis and monocyte-derived macrophage proliferation in the spleen. Because macrophages are integral part of the erythropoietic niche, our objective was to assess the macrophage compartment in transgenic sickle cell mice (SS) at steady state compared to AA controls. Furthermore, we used acute blood loss in C57BL/6J wild type (WT) to confirm if macrophage hypercellularity accompanies erythroid hyperplasia in a mouse model without erythrocytosis or sickling. Using flow cytometry, macrophages were identified with F4/80, CD45, CD11b and CD169, while erythroid progenitor cells were identified with Ter119 and CD71 in the BM and spleen of SS mice and age-matched control (AA) mice. Each subset of macrophages is 3.8 to 6.8-fold higher in SS mice bone marrow compared to AA at steady state (p≤0.05, Fig 1a). Findings were similar for other CD169 subsets in the spleens of SS mice. This macrophage hypercellularity was accompanied by expected erythroid hyperplasia, with 12-fold higher immature erythroid progenitor cells (CD71hiTer119hi) in SS mice than AA controls (p≤0.001). To confirm the increase in macrophage numbers that accompanied erythroid hyperplasia in SS mice as a response to erythroid stress, we induce stress with acute blood loss in WT mice by phlebotomy (once). Interestingly, we found macrophage hypercellularity accompanies erythroid hyperplasia in WT mice during recovery from acute blood loss. WT mice showed about 47-61% increases in CD169 macrophages subsets in the marrow and 47-83% increase in the spleen during recovery from acute blood loss (5-7 days) compared to untreated mice (Fig. 1b). This macrophage hypercellularity was accompanied with 88% increase in immature erythroid progenitor cell. Similarly, we investigated if there was age dependence in macrophage hypercellularity that accompanies erythroid hyperplasia in SS mice. In SS mice, there was no significant differences in macrophage numbers in the BM juvenile mice (5 weeks old) compared to young adults (14 weeks old), presumably because the higher demand for erythroid production to compensate for anemia had already started in the juvenile animals. However, there was a significantly higher macrophage hypercellularity in the spleen at 14 weeks compared to juvenile animals (p≤0.001). There was also a reduction in hematocrit (p≤0.05) and hemoglobin (p≤0.01) from 5 to 14 weeks in SS mice, although this does not correlate to either macrophage hypercellularity or erythroid hyperplasia. We also quantified mRNA expression of heme oxygenase 1 (Hmox1), a critical regulator of erythroid stress response, in the BM of untreated SS mice, and untreated and stressed WT mice. As expected, BM cells from SS mice at steady state expressed significantly higher Hmox1 expression than in WT mice (p≤0.001). Acute blood loss induced-stress raised the Hmox1 expression in WT mice to comparable levels to that of SS mice at steady state. Our investigation is the first to our knowledge to detect BM macrophage hypercellularity is associated with erythroid hyperplasia in response to acute blood loss and in congenital hemolytic anemia. Our data of macrophage hypercellularity in SCD opens up further research opportunity to elucidate the role of these cells in multiorgan complication in SCD. Figure 1: Macrophage hypercellularity accompanies erythroid hyperplasia in sickle cell disease and during recovery from acute blood loss. (a) BM macrophage quantification (per femur) in untreated sickle cell mice compared to AA controls (n = 5). Student's Ttest * SS mice compared to AA mice. (b) Acute blood loss induced macrophage hypercellularity in the BM of WT mice (n = 4 - 5). Student's Ttest * Untreated compared to stressed WT mice. Figure 1 Disclosures Ofori-Acquah: Shire Human Genetic Therapies Inc: Other: Financial Relationship. Kato:Novartis, Global Blood Therapeutics: Consultancy, Research Funding; Bayer: Research Funding." @default.
• W2987306747 created "2019-11-22" @default.
• W2987306747 creator A5019025963 @default.
• W2987306747 creator A5034254452 @default.
• W2987306747 creator A5037299691 @default.
• W2987306747 creator A5044642739 @default.
• W2987306747 creator A5066832003 @default.
• W2987306747 creator A5069489825 @default.
• W2987306747 creator A5091584609 @default.
• W2987306747 date "2019-11-13" @default.
• W2987306747 modified "2023-10-14" @default.
• W2987306747 title "Macrophage Hypercellularity Accompanies Erythroid Hyperplasia in Sickle Cell Mice and during Recovery from Blood Loss in Wild Type Mice" @default.
• W2987306747 doi "https://doi.org/10.1182/blood-2019-127224" @default.
• W2987306747 hasPublicationYear "2019" @default.
• W2987306747 type Work @default.
• W2987306747 sameAs 2987306747 @default.
• W2987306747 citedByCount "0" @default.
• W2987306747 crossrefType "journal-article" @default.
• W2987306747 hasAuthorship W2987306747A5019025963 @default.
• W2987306747 hasAuthorship W2987306747A5034254452 @default.
• W2987306747 hasAuthorship W2987306747A5037299691 @default.
• W2987306747 hasAuthorship W2987306747A5044642739 @default.
• W2987306747 hasAuthorship W2987306747A5066832003 @default.
• W2987306747 hasAuthorship W2987306747A5069489825 @default.
• W2987306747 hasAuthorship W2987306747A5091584609 @default.
• W2987306747 hasConcept C104317684 @default.
• W2987306747 hasConcept C126322002 @default.
• W2987306747 hasConcept C127716648 @default.
• W2987306747 hasConcept C134018914 @default.
• W2987306747 hasConcept C171779818 @default.
• W2987306747 hasConcept C201750760 @default.
• W2987306747 hasConcept C202751555 @default.
• W2987306747 hasConcept C203014093 @default.
• W2987306747 hasConcept C2776557347 @default.
• W2987306747 hasConcept C2777092883 @default.
• W2987306747 hasConcept C2777562237 @default.
• W2987306747 hasConcept C2778248108 @default.
• W2987306747 hasConcept C2779244956 @default.
• W2987306747 hasConcept C2779703530 @default.
• W2987306747 hasConcept C2779919695 @default.
• W2987306747 hasConcept C2780007613 @default.
• W2987306747 hasConcept C2780844101 @default.
• W2987306747 hasConcept C2780931953 @default.
• W2987306747 hasConcept C28328180 @default.
• W2987306747 hasConcept C553184892 @default.
• W2987306747 hasConcept C55493867 @default.
• W2987306747 hasConcept C71924100 @default.
• W2987306747 hasConcept C86803240 @default.
• W2987306747 hasConcept C95444343 @default.
• W2987306747 hasConceptScore W2987306747C104317684 @default.
• W2987306747 hasConceptScore W2987306747C126322002 @default.
• W2987306747 hasConceptScore W2987306747C127716648 @default.
• W2987306747 hasConceptScore W2987306747C134018914 @default.
• W2987306747 hasConceptScore W2987306747C171779818 @default.
• W2987306747 hasConceptScore W2987306747C201750760 @default.
• W2987306747 hasConceptScore W2987306747C202751555 @default.
• W2987306747 hasConceptScore W2987306747C203014093 @default.
• W2987306747 hasConceptScore W2987306747C2776557347 @default.
• W2987306747 hasConceptScore W2987306747C2777092883 @default.
• W2987306747 hasConceptScore W2987306747C2777562237 @default.
• W2987306747 hasConceptScore W2987306747C2778248108 @default.
• W2987306747 hasConceptScore W2987306747C2779244956 @default.
• W2987306747 hasConceptScore W2987306747C2779703530 @default.
• W2987306747 hasConceptScore W2987306747C2779919695 @default.
• W2987306747 hasConceptScore W2987306747C2780007613 @default.
• W2987306747 hasConceptScore W2987306747C2780844101 @default.
• W2987306747 hasConceptScore W2987306747C2780931953 @default.
• W2987306747 hasConceptScore W2987306747C28328180 @default.
• W2987306747 hasConceptScore W2987306747C553184892 @default.
• W2987306747 hasConceptScore W2987306747C55493867 @default.
• W2987306747 hasConceptScore W2987306747C71924100 @default.
• W2987306747 hasConceptScore W2987306747C86803240 @default.
• W2987306747 hasConceptScore W2987306747C95444343 @default.
• W2987306747 hasIssue "Supplement_1" @default.
• W2987306747 hasLocation W29873067471 @default.
• W2987306747 hasOpenAccess W2987306747 @default.
• W2987306747 hasPrimaryLocation W29873067471 @default.
• W2987306747 hasRelatedWork W2011623439 @default.
• W2987306747 hasRelatedWork W2019022460 @default.
• W2987306747 hasRelatedWork W2037714981 @default.
• W2987306747 hasRelatedWork W2110135497 @default.
• W2987306747 hasRelatedWork W2433836024 @default.
• W2987306747 hasRelatedWork W2472644284 @default.
• W2987306747 hasRelatedWork W2551373426 @default.
• W2987306747 hasRelatedWork W2987306747 @default.
• W2987306747 hasRelatedWork W3010121724 @default.
• W2987306747 hasRelatedWork W4313305814 @default.
• W2987306747 hasVolume "134" @default.
• W2987306747 isParatext "false" @default.
• W2987306747 isRetracted "false" @default.
• W2987306747 magId "2987306747" @default.
• W2987306747 workType "article" @default.